New Tissue Bulking Agent (Polyacrylate Polyalcohol) for Treating Vesicoureteral Reflux: Preliminary Results in Children

Journal of Urology

Volumn 183, Issue 2, 2010, Pages 714-718

  Ormaechea, M ^a   Ruiz, E ^a   Denes, E ^b   Gimenez, F ^b   Denes F T ^c   Moldes, J ^a   Amarante, A ^d   Pioner, G ^e   Dekermacher, S ^f   de Badiola, F ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

^e Hospital Santa Casa de Misericordia   (Brazil)

^f HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

Author keywords

acrylic resins; endoscopy; injections; Vantris; vesico ureteral reflux

Indexed keywords

BULKING AGENT; POLYACRYLATE POLYALCOHOL COPOLYMER; UNCLASSIFIED DRUG; VANTRIS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DYSURIA; FEMALE; HUMAN; INFANT; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; URETER OBSTRUCTION; URETER SURGERY; VESICOURETERAL REFLUX;

EID: 73749086488     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.10.047     Document Type: Article

References (24)

1. Khoury A., and Bagli D. Reflux and megaureter. In: Wein A.J., Kavoussi L.R., Novick A.C., et al. (Eds). Campbell-Walsh Urology. 9th ed. (2007), WB Saunders Co, Philadelphia 3423-3481 chapt 117
2. Ferrer F.A., McKenna P.H., Hochman H.I., et al. Results of a vesicoureteral reflux practice pattern survey among American Academy of Pediatrics, Section on Pediatric Urology members. J Urol 160 (1998) 1031
3. Ormaechea M., Paladini M., Pisano R., et al. Vantris, a biocompatible, synthetic, non-biodegradable, easy-to-inject bulking substance. Evaluation of local tissular reaction, localized migration and long-distance migration. Arch Esp Urol 61 (2008) 263
4. International Organization for Standardization. ISO 10993-1:2009: biological evaluation of medical devices-part 1: evaluation and testing within a risk management process. http://www.iso.org/iso/iso_catalogue/catalogue_ics/catalogue_ detail_ics.htm?csnumber=44908
5. Matouschek E. Treatment of vesicorenal reflux by transurethral teflon-injection. Urologe A 20 (1981) 263
6. O'Donnell B., and Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 289 (1984) 7
7. Kirsch A.J., Perez-Brayfield M., Smith E.A., et al. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171 (2004) 2413
8. Nelson C.P., Copp H.L., Lai J., et al. Is availability of endoscopy changing initial management of vesicoureteral reflux?. J Urol 182 (2009) 1152
9. Elder J.S., Diaz M., Caldamone A.A., et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175 (2006) 716
10. Malizia A.A., Reiman R.P., Myers J.R., et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251 (1984) 3277
11. Henly D.R., Barrett D.M., Weiland T.L., et al. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 153 (1995) 2039
12. Smith D.P., Kaplan W.E., and Oyasu R. Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 152 (1994) 1221
13. Cho E.R., Kang S.W., Park H.J., et al. Submucosal injection of poly(lactic-co-glycolic acid) microspheres in rabbit bladder as a potential treatment for urinary incontinence and vesicoureteral reflux: preliminary results. J Biomater Sci Polym Ed 16 (2005) 1109
14. Lackgren G., Wahlin N., Skoldenberg E., et al. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166 (2001) 1887
15. Oswald J., Riccabona M., and Radmayr C. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology 60 (2002) 894
16. Lorenzo A.J., Pippi Salle J.L., Barroso U., et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction?. Multivariate analysis of a single institution experience during 6 years. J Urol 176 (2006) 1851
17. Lee E.K., Gatti J.M., Demarco R.T., et al. Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup. J Urol 181 (2009) 1869
18. Cooper C.S., Chung B.I., Kirsch A.J., et al. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol 163 (2000) 269
19. Sedberry-Ross S., Rice D.C., Pohl H.G., et al. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid. J Urol 180 suppl (2008) 1605
20. Capozza N., Lais A., Matarazzo E., et al. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux. J Urol 168 (2002) 1695
21. Perez-Brayfield M., Kirsch A.J., Hensle T.W., et al. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 172 (2004) 1614
22. Lackgren G., Wahlin N., Skoldenberg E., et al. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney. J Urol 170 (2003) 1551
23. Vandersteen D.R., Routh J.C., Kirsch A.J., et al. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer. J Urol 176 (2006) 1593
24. Aaronson D.S., Siddiqui S.A., Reinberg Y., et al. Relative contraindication to endoscopic subureteral injection for vesicoureteral reflux: congenital refluxing megaureter with distal aperistaltic segment. Urology 71 (2008) 216